Andy McGibbon
Managing Partner @ Sonder Capital
San Francisco, United States
Andy McGibbon is a Series A investor at Sonder Capital in San Francisco focused on Health Care and Medical Device. Andy McGibbon is the Managing Partner of Sonder Capital. He attended the University of Cincinnati.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Andy McGibbon invests in
Stages Andy McGibbon invests in
Countries Andy McGibbon invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (50%)
- Medical Device 2 (50%)
- Diabetes 1 (25%)
- Biotechnology 1 (25%)
Stage
- Series A 2 (50%)
- Series B 1 (25%)
Country
- United States 1 (25%)
- The Netherlands 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Vitestro transform patient care with autonomous blood drawing technology. | $70M / Series B / Mar 10, 2026 | ||
| Vitestro transform patient care with autonomous blood drawing technology. | $12.9M / Series A / Mar 21, 2023 | ||
| G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology. This technology will allow less invasive surgery and offer the capability of developing more procedures new to the world. The company is creating a new category in healthcare designed to create less invasive surgery and reducehealthcare costs.G.I. Windows is committed to innovation that helps improve the way diagnostic and interventional procedures impact the essential balance between both patients and the healthcare system. It was founded in 2012 and is headquartered in West Bridgewater, Massachusetts, United States. | $16.4M / Series A / Aug 19, 2020 | ||
| G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology. This technology will allow less invasive surgery and offer the capability of developing more procedures new to the world. The company is creating a new category in healthcare designed to create less invasive surgery and reducehealthcare costs.G.I. Windows is committed to innovation that helps improve the way diagnostic and interventional procedures impact the essential balance between both patients and the healthcare system. It was founded in 2012 and is headquartered in West Bridgewater, Massachusetts, United States. | $14.6M / Series A / Dec 11, 2019 |
Co-Investors
About Sonder Capital
Sonder Capital invests in teams and technologies that can transform healthcare in the medical device, diagnostic and healthtech sectors. We are Foundational Investors – we commit our energy and capital early to guide and support companies from inception to acquisition or IPO. We look for big ideas that will change lives.
Sonder Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Andy McGibbon
Managing Partner
|
|||
Jay Watkins
Managing Partner
|
|||
Colby Wood
Managing Partner
|
|||
Fred Moll, M.D
Managing Partner
|
|||
Kate Garrett
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Andy McGibbon invest in?
Andy McGibbon invests primarily in Health Care, Medical Device and Diabetes startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Andy McGibbon?
Public channels for Andy McGibbon include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Andy McGibbon last invest?
The most recent investment recorded for Andy McGibbon closed in Mar 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
